Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations.

Genomic aberrations in a series of paired biopsy samples from patients who presented initially with follicle center lymphoma (FCL) and subsequently transformed to diffuse large B-cell lymphoma (DLBCL) were measured by array comparative genomic hybridization (CGH). The consequences of these aberrations on gene expression were determined by comparison with expression analysis on these specimens using cDNA microarrays. A heterogeneous pattern of acquired genomic abnormalities was observed upon transformation, some of which were recurrent in small subsets of patients. Some of the genomic aberration acquired upon transformation, such as gain/amplification of 1q21-q24, 2p16 (REL/BCL11A gene loci), 3q27-q29 (including the BCL6 locus), 7q11.2-q22.1, 12pter-q12, 18q21 (including the BCL2 locus) and Xq, and deletion of 6q22-q24, 13q14-q21 and 17p13 (P53 locus) have been previously implicated in the FCL/DLBCL pathogenesis. In addition, novel genomic imbalances not previously reported in association with FCL transformation, such as overrepresentation of 4p12-pter, 5p12-p15, 6p12.3-p21, 9p23, 9q13-q31, 16q, 17q21, and loss of 1p36.3, 4q21-q23, 5q21-q23, 9q31-qter, 11q24-q25, and 15q23, were identified. We observed a differential expression profile of many genes within regions of gain and deletion upon transformation, including novel target genes associated with FCL transformation. However, other genes did not show deregulated expression despite their location within these areas. In summary, the combination of array CGH and expression analysis provides a more comprehensive picture of the transformation of FCL to DLBCL. This process is associated with the acquisition of a variable spectrum of genomic imbalances affecting recurrent chromosomal areas that harbor overexpressed or underexpressed genes targeted upon transformation.

[1]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[2]  Ajay N. Jain,et al.  Fully automatic quantification of microarray image data. , 2002, Genome research.

[3]  P. Lichter,et al.  Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. , 1996, Blood.

[4]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[5]  J. Vermeesch,et al.  FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12. , 1997, Genes, chromosomes & cancer.

[6]  R. Siebert,et al.  Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. , 2002, Blood.

[7]  E. Campo,et al.  p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. , 1998, Blood.

[8]  R. Scheuermann,et al.  Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. , 2001, Blood.

[9]  F. Ajchenbaum‐Cymbalista,et al.  Overexpression of cyclin D2 in chronic B-cell malignancies. , 1995, Blood.

[10]  K. Offit,et al.  Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations. , 1991, Hematology/oncology clinics of North America.

[11]  K. Offit,et al.  p53 mutations are associated with histologic transformation of follicular lymphoma. , 1993, Blood.

[12]  M. Williams,et al.  Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. , 1989, The Journal of clinical investigation.

[13]  R. Warnke,et al.  Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. , 1996, Blood.

[14]  G. Gahrton,et al.  Amplification of multiple regions of chromosome 12, including 12q13–15, in chronic lymphocytic leukaemia , 1997, European journal of haematology.

[15]  K. Offit,et al.  REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. , 1996, Blood.

[16]  F Solé,et al.  Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. , 2001, Blood.

[17]  H. Ohno,et al.  Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. , 2000, Cancer research.

[18]  M. Balázs,et al.  Genetic instability is associated with histological transformation of follicle center lymphoma , 2000, Leukemia.

[19]  R. Siebert,et al.  High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. , 1996, Blood.

[20]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[21]  D. Longo,et al.  p53 mutation is associated with progression in follicular lymphomas. , 1993, Blood.

[22]  N. Kato,et al.  Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line , 1990, Journal of virology.

[23]  M. Urioste,et al.  Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas , 2000, Leukemia.

[24]  R. Siebert,et al.  Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization , 2001, Leukemia.

[25]  J. Cigudosa,et al.  Chromosomal and gene amplification in diffuse large B-cell lymphoma. , 1998, Blood.

[26]  G. Chenevix-Trench,et al.  Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer , 1995, International journal of cancer.

[27]  H. Döhner,et al.  Mantle cell lymphoma is characterized by inactivation of the ATM gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Döhner,et al.  Gain of chromosome arm 9p is characteristic of primary mediastinal b‐cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line , 2001, Genes, chromosomes & cancer.

[29]  Stefan Joos,et al.  Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. , 2002, Blood.

[30]  A. López-Guillermo,et al.  Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. , 1999, Blood.

[31]  Annick,et al.  Prognostic value of chromosomal abnormalities in follicular lymphoma. , 1994, Blood.

[32]  R. Gascoyne,et al.  Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18) , 2001, Genes, chromosomes & cancer.

[33]  R. Siebert,et al.  Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis , 2001, Leukemia.

[34]  D G Oscier,et al.  The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. , 2001, Blood.

[35]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[36]  M. Oken,et al.  Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.

[37]  S. Horning,et al.  The natural history of initially untreated low-grade non-Hodgkin's lymphomas. , 1984, The New England journal of medicine.

[38]  M. Taniwaki,et al.  Establishment of a novel human B‐cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes , 1997, Hematological oncology.

[39]  P. Lorigan,et al.  Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma , 2001, British Journal of Cancer.

[40]  I. Lossos,et al.  Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene. , 2000, Blood.

[41]  J. Vermeesch,et al.  FISH identifies different types of duplications with 12q13‐15 as the commonly involved segment in B‐cell lymphoproliferative malignancies characterized by partial trisomy 12 , 1997 .

[42]  C. Croce,et al.  ATM mutations in B-cell chronic lymphocytic leukemia. , 1999, Cancer research.

[43]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[44]  T. Lister,et al.  The use of real‐time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma , 2000, British journal of haematology.

[45]  M. Minden,et al.  Molecular cytogenetic characterization of non‐Hodgkin lymphoma cell lines , 2002, Genes, chromosomes & cancer.

[46]  R. Bataille,et al.  Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas , 1997, British journal of haematology.

[47]  E. Campo,et al.  Gene Inactivation by Deletions , Mutations , and Hypermethylation Is Associated With Transformed and Aggressive Variants of Non-Hodgkin ’ s Lymphomas , 1998 .

[48]  E. Campo,et al.  p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. , 1998, Blood.

[49]  David Botstein,et al.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Salles,et al.  Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.